The following alerts have been recently posted to the Medi-Cal Rx Web Portal:  

Also in California, the Department of Health Care Services posted this article to the Medi-Cal Rx Web Portal: Professional Organizations Push for Recall of Buprenorphine Dental Warning.  

Also, in California, COVID-19 related news highlighted below: 

Finally in California, the Board of Pharmacy released Notices of Modified Text for the following and will accept written comments on the proposed modifications until March 2, 2022. 

  • Self-Assessment of a Wholesaler/Third-Party Logistics Provider by the Designated Representative-In-Charge or Responsible Manager 
  • Self-Assessment of a Pharmacy by the Pharmacist-in-Charge 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.